Conclusions
death, T2DM
CARDIOVASCULAR DISEASE, INSULIN SENSITIVITY
The pilot trial provided good evidence to suggest that chronic dietary supplementation with a novel cysteine-rich keratin protein blend may produce a clinically-relevant improvement in whole-body glucose clearance and aspects of muscle insulin sensitivity in humans with T2DM. These changes were associated within good evidence for redox-state shifts responding to insulin, increased antioxidant protein expression, GLUT4 translocation, and higher microvascular blood flow responses within the skeletal muscle tissue. The keratin protein was largely acceptable within baked products and capsules. As cysteine, glycine, and arginine are inversely correlated with cardiovascular disease - the primary cause of death in people with T2DM [